Hudock Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-90
| Closed | -$61K | – | 588 |
|
2022
Q3 | $61K | Hold |
90
| – | – | 0.02% | 274 |
|
2022
Q2 | $53K | Hold |
90
| – | – | 0.02% | 294 |
|
2022
Q1 | $62K | Hold |
90
| – | – | 0.02% | 295 |
|
2021
Q4 | $56K | Hold |
90
| – | – | 0.02% | 315 |
|
2021
Q3 | $54K | Hold |
90
| – | – | 0.02% | 309 |
|
2021
Q2 | $50K | Hold |
90
| – | – | 0.01% | 320 |
|
2021
Q1 | $42K | Hold |
90
| – | – | 0.01% | 338 |
|
2020
Q4 | $43K | Hold |
90
| – | – | 0.01% | 318 |
|
2020
Q3 | $50K | Hold |
90
| – | – | 0.02% | 275 |
|
2020
Q2 | $56K | Hold |
90
| – | – | 0.02% | 254 |
|
2020
Q1 | $43K | Hold |
90
| – | – | 0.02% | 245 |
|
2019
Q4 | $33K | Hold |
90
| – | – | 0.01% | 289 |
|
2019
Q3 | $24K | Hold |
90
| – | – | 0.01% | 326 |
|
2019
Q2 | $28K | Hold |
90
| – | – | 0.01% | 307 |
|
2019
Q1 | $36K | Hold |
90
| – | – | 0.01% | 277 |
|
2018
Q4 | $32K | Hold |
90
| – | – | 0.01% | 275 |
|
2018
Q3 | $36K | Hold |
90
| – | – | 0.01% | 283 |
|
2018
Q2 | $31K | Hold |
90
| – | – | 0.01% | 285 |
|
2018
Q1 | $30K | Hold |
90
| – | – | 0.01% | 302 |
|
2017
Q4 | $33K | Hold |
90
| – | – | 0.01% | 289 |
|
2017
Q3 | $40K | Hold |
90
| – | – | 0.02% | 266 |
|
2017
Q2 | $44K | Hold |
90
| – | – | 0.02% | 243 |
|
2017
Q1 | $34K | Hold |
90
| – | – | 0.02% | 267 |
|
2016
Q4 | $33K | Hold |
90
| – | – | 0.02% | 265 |
|
2016
Q3 | $36K | Sell |
90
-50
| -36% | -$20K | 0.02% | 262 |
|
2016
Q2 | $48K | Buy |
140
+50
| +56% | +$17.1K | 0.03% | 235 |
|
2016
Q1 | $32K | Hold |
90
| – | – | 0.02% | 283 |
|
2015
Q4 | $48K | Hold |
90
| – | – | 0.02% | 216 |
|
2015
Q3 | $41K | Hold |
90
| – | – | 0.02% | 236 |
|
2015
Q2 | $45K | Hold |
90
| – | – | 0.02% | 222 |
|
2015
Q1 | $41K | Hold |
90
| – | – | 0.02% | 245 |
|
2014
Q4 | $37K | Hold |
90
| – | – | 0.02% | 242 |
|
2014
Q3 | $32K | Sell |
90
-75
| -45% | -$26.7K | 0.02% | 261 |
|
2014
Q2 | $47K | Buy |
+165
| New | +$47K | 0.05% | 215 |
|